TDOC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Teladoc Health Inc (TDOC) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is in a bearish technical trend, has weak financial performance, and lacks positive catalysts to support a recovery in the near term. Additionally, analysts have consistently lowered price targets, and options data indicates bearish sentiment. Given the investor's profile and the current state of the stock, it is better to hold off on investing in TDOC for now.
The technical indicators for TDOC are bearish. The MACD histogram is negative and expanding downward, RSI is at 15.761 indicating oversold conditions, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its S1 support level at 4.52, with resistance at 5.035 and 5.551. The stock has a 70% chance to decline further in the short term.
NULL identified. No recent positive news or events to act as a catalyst for the stock's recovery.
Analysts have consistently lowered price targets, reflecting weak sentiment.
Financial performance shows declining revenue (-2.20% YoY) and gross margin (-11.85% YoY).
Options data and technical indicators point to bearish sentiment and a likely continued decline in stock price.
In Q3 2025, Teladoc's revenue dropped by 2.20% YoY to $626.4M. Net income improved but remains negative at -$49.51M, up 48.78% YoY. EPS improved to -0.28, up 47.37% YoY. Gross margin declined significantly to 56.01%, down 11.85% YoY. Overall, the financials show weak growth trends.
Analysts have lowered price targets consistently over the past few months. The current price targets range from $7 to $9, with most analysts maintaining Neutral ratings. While some analysts remain cautiously optimistic about 2026, the overall sentiment is weak, with no strong buy recommendations.
